Clinical characteristics of patients with COVID-19 with or without new-onset CVD
| Total (N=219) | COVID-19 with CVD (n=11) | COVID-19 without CVD (n=208) | P value* | |
| Age (years), mean±SD | 53.3±15.9 | 75.7±10.8 | 52.1±15.3 | |
| Age (years), n (%) | <0.001 | |||
| <60 | 132 (60.3) | 1 (9.1) | 131 (63.0) | |
| ≥60 | 87 (39.7) | 10 (90.9) | 77 (37.0) | |
| Sex, n (%) | 0.360 | |||
| Female | 130 (59.4) | 5 (45.5) | 125 (60.1) | |
| COVID-19 | 0.009 | |||
| Severe | 92 (42.0) | 9 (81.8) | 83 (39.9) | |
| Non-severe | 127 (58.0) | 2 (18.2) | 125 (60.1) | |
| Medical history, n (%) | ||||
| Any | 85 (38.8) | 10 (90.9) | 75 (36.1) | <0.001 |
| Hypertension | 55 (25.1) | 9 (81.8) | 46 (22.1) | <0.001 |
| Diabetes | 31 (14.2) | 6 (54.5) | 25 (12.0) | 0.001 |
| Heart disease and CVD | 17 (7.8) | 3 (27.3) | 14 (6.7) | 0.044 |
| Malignancy | 14 (6.4) | 1 (9.1) | 13 (6.3) | 0.525 |
Data are presented as mean±SD and n/N (%).
P values indicate differences between patients with COVID-19 with and without new-onset CVD. P<0.05 was considered statistically significant.
*Fisher exact test.
CVD, cerebrovascular disease.